What is a stock summary page? Click here for an overview.
Business Description
Aion Therapeutic Inc
NAICS : 325411
SIC : 3741
ISIN : CA00905T1021
Share Class Description:
ANTCF: Ordinary SharesDescription
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -2.66 | |||||
| Debt-to-Equity | -0.59 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -40.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35.3 | |||||
| 3-Year EPS without NRI Growth Rate | 69.1 | |||||
| 3-Year FCF Growth Rate | 57.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 3.05 | |||||
| 9-Day RSI | 21.1 | |||||
| 14-Day RSI | 35.38 | |||||
| 3-1 Month Momentum % | -64.29 | |||||
| 6-1 Month Momentum % | -50.89 | |||||
| 12-1 Month Momentum % | -63.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.25 | |||||
| Quick Ratio | 0.15 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 269.38 | |||||
| Days Sales Outstanding | 16.98 | |||||
| Days Payable | 1398.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -48.8 | |||||
| Shareholder Yield % | -34.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.65 | |||||
| Operating Margin % | -137.48 | |||||
| Net Margin % | -585.3 | |||||
| FCF Margin % | -108.92 | |||||
| ROA % | -347.68 | |||||
| ROIC % | -49.21 | |||||
| 3-Year ROIIC % | 284.77 | |||||
| ROC (Joel Greenblatt) % | -4215.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.33 | |||||
| EV-to-EBIT | -1.12 | |||||
| EV-to-EBITDA | -1.14 | |||||
| EV-to-Revenue | 6.33 | |||||
| EV-to-FCF | -5.78 | |||||
| Earnings Yield (Greenblatt) % | -89.29 | |||||
| FCF Yield % | -25.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ANTCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aion Therapeutic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.841 | ||
| EPS (TTM) ($) | -0.013 | ||
| Beta | 9.38 | ||
| 3-Year Sharpe Ratio | 1.08 | ||
| 3-Year Sortino Ratio | 4.06 | ||
| Volatility % | 462.55 | ||
| 14-Day RSI | 35.38 | ||
| 14-Day ATR ($) | 0.000067 | ||
| 20-Day SMA ($) | 0.0055 | ||
| 12-1 Month Momentum % | -63.33 | ||
| 52-Week Range ($) | 0.0035 - 0.0475 | ||
| Shares Outstanding (Mil) | 497.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aion Therapeutic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aion Therapeutic Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aion Therapeutic Inc Frequently Asked Questions
What is Aion Therapeutic Inc(ANTCF)'s stock price today?
The current price of ANTCF is $0.01. The 52 week high of ANTCF is $0.05 and 52 week low is $0.00.
When is next earnings date of Aion Therapeutic Inc(ANTCF)?
The next earnings date of Aion Therapeutic Inc(ANTCF) is .
Does Aion Therapeutic Inc(ANTCF) pay dividends? If so, how much?
Aion Therapeutic Inc(ANTCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers